

I have established a strong foundation in bacteriophage biology, bacterial pathogenesis, and antimicrobial innovation through diverse, multidisciplinary research experiences. My work ranges from phage-host molecular interactions in Mycobacterium smegmatis, where I identified critical residues in Msmeg_5894 essential for Phage Brilliant infection, to developing and characterizing bacteriophage cocktails targeting Enterococcus faecalis infective endocarditis and better understanding phage-antibiotic synergy. Additionally, I have investigated nontuberculous mycobacterial localization using advanced imaging techniques (MiPACT-HCR), optimized Staphylococcus aureus biofilm models for phage and antimicrobial testing, and contributed to ultrasound-based strategies for targeted antimicrobial delivery. Collectively, my research integrates molecular microbiology, therapeutic development, and translational innovation to address the global challenge of antibiotic resistance.